{"lastClose": 40.439998626708984, "len": 262, "date": "2023-01-24", "alpha_1": 1.8168751627427113, "beta_1": 1.0430924456779371, "drawup_1": 4.903649516748157, "sharpe_1": 1.2401822353048684, "natr_1": 5.394419246874847, "sup_1": -0.24559012868755262, "res_1": 0.11811744966537915, "bullPattern_1": [], "bearPattern_1": [], "rsi_1": 54.66453449839649, "adx_1": 13.68390207005085, "drawdown_1": -0.7917933256250944, "stratHoldSharpe_1": 1.185541893667919, "stratHoldAlpha_1": 252.1938431044859, "stratHoldDrawdown_1": -0.7437898668279697, "alpha_3mo": 0.2071325553038832, "beta_3mo": 1.1138586113165, "drawup_3mo": 0.2329268160779725, "sharpe_3mo": 0.7946668862872593, "natr_3mo": 5.394419246874847, "sup_3mo": -0.04558186067996887, "res_3mo": 0.013682915824891052, "bullPattern_3mo": [], "bearPattern_3mo": [], "rsi_3mo": 65.83806287097114, "adx_3mo": 21.951215748804064, "drawdown_3mo": -0.15231787564688803, "stratHoldSharpe_3mo": 1.2305535234250795, "stratHoldAlpha_3mo": 251.55017496530823, "stratHoldDrawdown_3mo": -0.13824103059618187, "Name": "Amylyx Pharmaceuticals Inc.", "Industry": "Biotechnology: Pharmaceutical Preparations", "IPO Year": 2022.0, "Market Cap": 2682051705, "Sector": "Health Care", "Country": "United States", "alpha%_1": 0.9999999998855915, "beta%_1": 0.5509803725238518, "drawup%_1": 1.0, "sharpe%_1": 0.7526415741244984, "natr%_1": 0.7304650876510346, "drawdown%_1": 0.021647288818720783, "stratHoldSharpe%_1": 0.9236297111118297, "stratHoldAlpha%_1": 0.9999922031729825, "stratHoldDrawdown%_1": 0.017078602539579837, "alpha%_3mo": 0.5170795567452607, "beta%_3mo": 0.6016578577012122, "drawup%_3mo": 0.4668508726409298, "sharpe%_3mo": 0.127099931017652, "natr%_3mo": 0.7305447659429803, "drawdown%_3mo": 0.5263320868745052, "stratHoldSharpe%_3mo": 0.4899279969693079, "stratHoldAlpha%_3mo": 0.6051292120340125, "stratHoldDrawdown%_3mo": 0.5275751663194581}